In fact, earlier in vitro studies have shown that the stimulation of normal and tumor-derived endothelial cells with angiogenic growth factors (VEGF, bFGF) results in substantially suppressed ICAM-1 expression [32]. This evidence concerns the gene ICAM1 and neoplasm.